Funded Biotechnology Startups in Berlin
Disclosed funding in this Berlin biotechnology list is highly uneven: the largest disclosed round is T-knife’s $110M (Series B) on 2021-08-02, which dwarfs…
Disclosed funding in this Berlin biotechnology list is highly uneven: the largest disclosed round is T-knife’s $110M (Series B) on 2021-08-02, which dwarfs the next-largest disclosed amounts seen here ($36M on 2025-01-14 by Formo; $19M on 2022-01-02 by Noxxon Pharma; and $15M on 2024-10-10 by Booster Therapeutics). Most other disclosed rounds cluster in smaller single-digit-to-mid-teens levels, with a handful of $12M–$14M checks (Sanity Group $12M on 2024-06-25; Dopavision $14M on 2021-07-14).
Stage and disclosure patterns also stand out. Among 23 rows, 2 amounts are “undisclosed” (Tacalyx on 2026-04-29; Viride on 2024-07-03), and 5 entries use “Series Unknown” (Pheiron 2025-06-20 $4M; Formo 2025-01-14 $36M; TME Pharma 2024-10-31 $3M; Sanity Group 2024-06-25 $12M; Cultimate Foods 2024-04-24 $3M). Temporally, the span runs from 2020-08-18 (MushLabs) to 2026-05-27 (Pacifico Biolabs), and the most recent entries cluster in 2024–2025 with multiple $2M–$4M disclosed rounds (e.g., Exazyme $2M on 2023-05-15 and Nia Health $4M on 2023-05-15).
Most recent rounds
23 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Berlin biotech set, and is it an outlier versus the rest?
The largest disclosed amount is T-knife’s $110M (Series B) on 2021-08-02. It is far above the next-largest disclosed rounds in the table, including Formo’s $36M on 2025-01-14 and Noxxon Pharma’s $19M on 2022-01-02.
Are “undisclosed” or “Series Unknown” classifications common enough to affect comparisons by stage?
Yes. Of 23 rows, 2 list the amount as “undisclosed” (Tacalyx 2026-04-29; Viride 2024-07-03), and 5 entries are labeled “Series Unknown” even when amounts are disclosed (including Pheiron $4M on 2025-06-20 and Sanity Group $12M on 2024-06-25).
Where do the funding dates concentrate within the 2020–2026 window shown?
The table runs from 2020-08-18 (MushLabs, amount $10M) to 2026-05-27 (Pacifico Biolabs, $8M). The most recent cluster is 2024–2025, including multiple $3M–$4M disclosed rounds such as Cultimate Foods $3M on 2024-04-24, TME Pharma $3M on 2024-10-31, and Nuuron $4M on 2024-10-31.
Which companies repeat across stages, suggesting multiple financings captured in this window?
Pacifico Biolabs appears twice: a Pre-Seed for $3M on 2024-02-16 and a Series A for $8M on 2026-05-27. Otherwise, most names are single-entry within the 23-row slice (for example, Formo only appears once with $36M on 2025-01-14).
Do any financing amounts form a visible “band” that dominates disclosed rounds here?
Aside from T-knife’s $110M outlier, many disclosed rounds sit in the lower bands. Examples include several $3M–$4M rounds (Nuuron $4M on 2024-10-31; TME Pharma $3M on 2024-10-31; Cultimate Foods $3M on 2024-04-24; Pheiron $4M on 2025-06-20), plus a smaller set of mid-teens checks (Dopavision $14M on 2021-07-14; Booster Therapeutics $15M on 2024-10-10).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.